MarieLadefogedFoeghMD

Internal Medicine • Washington, DC

Women's Health

Physician

Join to view full profile

Dr. Foegh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Foegh's full profile

Already have an account?

Office
3800 Reservoir Rd NW
PVC F6003
Washington, DC 20007
Phone+1 201-981-5007

Fax+1 201-227-9527

Education & Training

University of Copenhagen Medical SchoolClass of 1969

Certifications & Licensure

MD State Medical License 1988 - 2026
DC State Medical License 1981 - 2024
VA State Medical License 1982 - 2024
GA State Medical License 1998 - 2017

Publications & Presentations

PubMed

1 citations
A novel drug specific mRNA biomarker predictor for selection of patients responding to dovitinib treatment of advanced renal cell carcinoma and other solid tumors.
Steen Knudsen, Anker Hansen, Marie Foegh, Steen Petersen, Hana Mekonnen
Plos One. 2023-01-01
44 citations
First-in-human study of the PARP/tankyrase inhibitor E7449 in patients with advanced solid tumours and evaluation of a novel drug-response predictor.
Ruth Plummer, Divyanshu Dua, Nicola Cresti, Yvette Drew, Peter Stephens
British Journal of Cancer. 2020-06-11
4 citations
New contraceptive patch wearability assessed by investigators and participants in a randomized phase 3 study.
Andrew M. Kaunitz, David Portman, Carolyn Westhoff, Daniel R. Mishell, David F. Archer
Contraception. 2015-03-01

Press Mentions

Allarity Therapeutics to Present a Dovitinib-DRP® E-poster at the European Association for Cancer Research (EACR) 2021 Virtual CongressApril 29th, 2021
Allarity Therapeutics (NASDAQ: ALLR) Reports Early Success in Phase 2 Trial for Breast Cancer Drug IXEMPRA®July 6th, 2023

Grant Support

Estrogen Inhibits Accelerated Graft ArteriosclerosisNational Heart, Lung, And Blood Institute1997
Forth Alexis Carrel Conference ProceedingsNational Heart, Lung, And Blood Institute1992
Thromboxone In Ischemic Heart DiseaseNational Heart, Lung, And Blood Institute1988–1992
Gonadol Steroids And Transplant AtherosclerosisNational Heart, Lung, And Blood Institute1988–1992
Thromboxane &Leukotrienes In Heart Transplant RejectionNational Heart, Lung, And Blood Institute1986–1988

Professional Memberships

Industry Relationships

Chief Medical Officer, Oncology Venture US, Inc.2017 - Present
Chair Board of Directors, Injecto2015 - Present